Adagene (ADAG – Research Report) received a Hold rating and price target from Morgan Stanley analyst Maxwell Skor today. The company’s shares ...

Morgan Stanley analyst Maxwell Skor maintained a Buy rating on Pharvaris (PHVS – Research Report) today and set a price target of $34.00. The ...

Repare Therapeutics Inc. (NASDAQ:RPTX – Get Free Report) was the recipient of a significant decrease in short interest in January. As of January 15th, there was short interest totalling 1,130,000 ...

the radiopharma is reducing its workforce by up to 13% and moving some roles from Denmark to the U.S. Release Jan. 10 - Repare Therapeutics: Repare is making more cuts. After announcing a 25% head ...

Among the casualties is camonsertib (also known as RP-3500), a small-molecule ATR protein kinase inhibitor licensed from Repare Therapeutics in 2022 in a deal that included $125 million upfront ...

After hours: January 28 at 4:02:32 PM EST Loading Chart for RPTX ...

After hours: January 27 at 5:13:36 PM EST ...

Featured here, the Income Statement (earnings report) for Repare Therapeutics Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and ...